UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053833
Receipt number R000061442
Scientific Title Research on laryngeal mycosis in laryngeal symptoms
Date of disclosure of the study information 2024/03/12
Last modified on 2024/03/12 11:32:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on laryngeal mycosis in laryngeal symptoms

Acronym

Research on laryngeal mycosis

Scientific Title

Research on laryngeal mycosis in laryngeal symptoms

Scientific Title:Acronym

Research on laryngeal mycosis in laryngeal symptoms

Region

Japan


Condition

Condition

Patients complaining of abnormal laryngeal sensation

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of the relationship between abnormal laryngeal sensation and fungal colonization of the laryngeal mucosa

Basic objectives2

Others

Basic objectives -Others

Based on the concept of one airway, one disease in the airway, it is possible that fungal colonization may also be associated with the larynx. In this study, sputum and pharyngeal swab samples will be collected from patients who complain of laryngeal discomfort. Fungi will be isolated and cultured to investigate the relationship with fungal colonization in the laryngeal mucosa.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fungal expression in sputum and pharyngeal swabs

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

89 years-old >=

Gender

Male and Female

Key inclusion criteria

Select those that meet all of the selection criteria below. However, if it meets one or more of the exclusion criteria, it will be excluded.
(1) Patients with laryngeal symptoms who received treatment between the date of approval and December 31, 2024
(2) Patients who are able to obtain written consent for participation in the study from their own free will.
(3) Patients who are at least 20 years old and less than 90 years old at the time of obtaining consent
(4) Gender: Any gender
(5) Inpatients / outpatients: Outpatients

Key exclusion criteria

(1) Severe hepatic or renal dysfunction
(2) Pregnant patients

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Marie
Middle name
Last name Yamada

Organization

International University of Health and Welfare Narita Nospital

Division name

Otorhinolaryngology, Head and Neck Surgery

Zip code

2868520

Address

852, Hatakeda, Narita, Chiba

TEL

0476355600

Email

myamada@iuhw.ac.jp


Public contact

Name of contact person

1st name Marie
Middle name
Last name Yamada

Organization

International University of Health and Welfare Narita Nospital

Division name

Otorhinolaryngology, Head and Neck Surgery

Zip code

2868520

Address

852, Hatakeda, Narita, Chiba

TEL

0476355600

Homepage URL


Email

myamada@iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare Narita Nospital

Institute

Department

Personal name



Funding Source

Organization

International University of Health and Welfare Narita Nospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of International University of Health and Welfare, Chiba District

Address

852, Hatakeda, Narita, Chiba

Tel

0476355600

Email

rinri_md@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 09 Month 28 Day

Date of IRB

2022 Year 09 Month 28 Day

Anticipated trial start date

2022 Year 09 Month 28 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Laryngeal findings; observation of the laryngeal mucosa using a laryngeal fiberscope. Collection of sputum and pharyngeal swab. Blood test; fungus-specific IgE antibody titer, etc. Evaluation using the QOL questionnaire for cough and abnormal laryngeal sensation.


Management information

Registered date

2024 Year 03 Month 12 Day

Last modified on

2024 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061442


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name